Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1087)
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
15,580
Price
$6.91
Total Value
$107.66K
Shares Held After
700,000
% of Holdings
2.2%
AbCellera Biologics Inc. (ABCL)
Montalbano John S. — Director
Shares
20,000
Price
$4.77
Total Value
$95.40K
Shares Held After
241,000
% of Holdings
8.3%
CEL SCI CORP (CVM)
KERSTEN GEERT R — Director
Shares
300,000
Price
$1.20
Total Value
$360.00K
Shares Held After
311,547
% of Holdings
96.3%
Orchestra BioMed Holdings, Inc. (OBIO)
Fain Eric S — Director
Shares
20,000
Price
$4.13
Total Value
$82.60K
Shares Held After
91,709
% of Holdings
21.8%
Karyopharm Therapeutics Inc. (KPTI)
Paulson Richard A. — Director
Shares
2,203
Price
$9.50
Total Value
$20.93K
Shares Held After
269,747
% of Holdings
0.8%
Karyopharm Therapeutics Inc. (KPTI)
Mano Michael — EVP, CLO&Secretary
Shares
266
Price
$9.50
Total Value
$2.53K
Shares Held After
94,398
% of Holdings
0.3%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$58.62
Total Value
$1.47M
Shares Held After
1,223,095
% of Holdings
2.0%
Karyopharm Therapeutics Inc. (KPTI)
Cheng Sohanya Roshan — EVP & Chief Commercial Officer
Shares
324
Price
$9.50
Total Value
$3.08K
Shares Held After
107,940
% of Holdings
0.3%
Karyopharm Therapeutics Inc. (KPTI)
Rangwala Reshma — EVP & Chief Medical Officer
Shares
408
Price
$9.50
Total Value
$3.88K
Shares Held After
56,829
% of Holdings
0.7%
Karyopharm Therapeutics Inc. (KPTI)
Abate Kristin — Chief Accounting Officer
Shares
53
Price
$9.50
Total Value
$503.50
Shares Held After
23,801
% of Holdings
0.2%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
10,479
Price
$117.54
Total Value
$1.23M
Shares Held After
64,910
% of Holdings
13.9%
Karyopharm Therapeutics Inc. (KPTI)
Poulton Stuart — EVP, Chief Development Officer
Shares
403
Price
$9.50
Total Value
$3.83K
Shares Held After
94,821
% of Holdings
0.4%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
3,220
Price
$78.68
Total Value
$253.35K
Shares Held After
242,662
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$578.29
Total Value
$208.19K
Shares Held After
40,513
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
232
Price
$576.88
Total Value
$133.84K
Shares Held After
40,873
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
983
Price
$575.98
Total Value
$566.19K
Shares Held After
41,105
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,922
Price
$575.02
Total Value
$1.68M
Shares Held After
42,088
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,283
Price
$574.21
Total Value
$1.89M
Shares Held After
45,010
% of Holdings
6.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
744
Price
$572.90
Total Value
$426.24K
Shares Held After
48,293
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$572.04
Total Value
$320.34K
Shares Held After
49,037
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
376
Price
$571.04
Total Value
$214.71K
Shares Held After
49,597
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$568.69
Total Value
$22.75K
Shares Held After
49,973
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$578.59
Total Value
$46.29K
Shares Held After
18,876
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
307
Price
$577.93
Total Value
$177.42K
Shares Held After
18,956
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
293
Price
$576.75
Total Value
$168.99K
Shares Held After
19,263
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,712
Price
$575.78
Total Value
$985.74K
Shares Held After
19,556
% of Holdings
8.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
3,419
Price
$574.76
Total Value
$1.97M
Shares Held After
21,268
% of Holdings
13.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,456
Price
$574.04
Total Value
$1.41M
Shares Held After
24,687
% of Holdings
9.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
970
Price
$572.78
Total Value
$555.60K
Shares Held After
27,143
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
603
Price
$571.53
Total Value
$344.63K
Shares Held After
28,113
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$570.52
Total Value
$45.64K
Shares Held After
28,716
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$568.74
Total Value
$45.50K
Shares Held After
28,796
% of Holdings
0.3%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
2,572
Price
$72.46
Total Value
$186.37K
Shares Held After
393,998
% of Holdings
0.6%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
2,100
Price
$73.08
Total Value
$153.47K
Shares Held After
396,570
% of Holdings
0.5%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
7,221
Price
$73.08
Total Value
$527.71K
Shares Held After
398,670
% of Holdings
1.8%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
679
Price
$73.06
Total Value
$49.61K
Shares Held After
405,891
% of Holdings
0.2%
Royalty Pharma plc (RPRX)
Norden Gregory — Director
Shares
3,045
Price
$53.00
Total Value
$161.38K
Shares Held After
191,803
% of Holdings
1.6%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
50,000
Price
$20.09
Total Value
$1.00M
Shares Held After
1,122,626
% of Holdings
4.3%
Zai Lab Ltd (ZLAB)
Edmondson Frazor Titus III — Chief Legal Officer
Shares
3,517
Price
$20.19
Total Value
$71.01K
Shares Held After
19,849
% of Holdings
15.1%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
13,684
Price
$53.06
Total Value
$726.14K
Shares Held After
31,881
% of Holdings
30.0%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,717
Price
$12.86
Total Value
$227.84K
Shares Held After
195,178
% of Holdings
8.3%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$77.92
Total Value
$584.40K
Shares Held After
400,330
% of Holdings
1.8%
Adlai Nortye Ltd. (ANL)
LU YANG — Director
Shares
10
Price
$13.18
Total Value
$131.80
Shares Held After
99,990
% of Holdings
0.0%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
75,178
Price
$14.00
Total Value
$1.05M
Shares Held After
909,843
% of Holdings
8.3%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
4,081
Price
$13.80
Total Value
$56.31K
Shares Held After
834,665
% of Holdings
0.5%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
1,341
Price
$82.58
Total Value
$110.74K
Shares Held After
1,115,987
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
18,659
Price
$82.05
Total Value
$1.53M
Shares Held After
1,117,328
% of Holdings
1.6%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$56.29
Total Value
$1.41M
Shares Held After
1,248,095
% of Holdings
2.0%
INSMED Inc (INSM)
Bonstein Sara — Chief Financial Officer
Shares
8,272
Price
$116.18
Total Value
$961.04K
Shares Held After
71,486
% of Holdings
10.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
13,283
Price
$116.18
Total Value
$1.54M
Shares Held After
287,902
% of Holdings
4.4%
Showing 1001–1050 of 1087 transactions (page 21 of 22)